UBS maintains Colgate-Palmolive at Buy

An UBS analyst maintained Colgate-Palmolive (NYSE: CL) at Buy and a price target of $86.00 from a prior price target of $84.00.
Prior to this rating, Colgate-Palmolive had 11 buy ratings, 14 hold ratings, and 0 sell ratings.
For consensus analyst estimates and price targets on Colgate-Palmolive, click here. For more news on Colgate-Palmolive, click here.
Colgate-Palmolive's stock price closed at $74.50. They are up 1.64% in the last month and down -1.94% in the last 12 months.
According to Investing Pro, Colgate-Palmolive's fair value is $80.65, an upside of 8.26%. Colgate-Palmolive's fair value comes with a low degree of uncertainty, according to InvestingPro.
Check out Colgate-Palmolive's recent earnings performance and financials here.

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb
Drop an image here or